Mukka Proteins IPO: Top Things to Know Before Subscribing to The Issue

Mukka Proteins opened the initial public offer (IPO) for subscription on February 29, 2024, and will close the issue on March 4, 2024. The company has fixed the IPO price band in the range of Rs 26 to Rs 28 per equity share of the face value of Re 1. The IPO lot size is 535 equity shares, and investors can subscribe in multiples of 535 equity shares thereafter.

About the company

Mukka Proteins Limited, a company specializing in animal protein, is primarily involved in producing Fish Meal, Fish Oil, and Fish Soluble Paste. Additionally, the company is working on developing alternative proteins, such as Black Soldier Fly (BSF) Insect meal, in the animal food segment. The fully mechanized plant, located in Karnataka.

Price Band

The company has fixed the IPO price band in the range of Rs 26 to Rs 28 per equity share.

Issue Size

Mukka Proteins IPO, which is worth Rs 224 crore, comprises a fresh issue of 8,00,00,000 equity shares with a face value of Re 1. This is a completely fresh issue, and there is no offer-for-sale component.

Also read: Bharat Highways InvIT IPO: Check Out Price Band, Issue Size & More

IPO Reserve Portion

• Qualified Institutional Buyers (QIB): Not more than 50% of the shares in the public issue
• Non-Institutional Investors (NII): Not less than 15% of the shares in the public issue
• Retail Investors: Not less than 35% of the offer

Objectives of the Issue

The company plans to utilize the net proceeds from the issue for:

1. General corporate needs
2. Investment in their associate, Ento Proteins Private Limited
3. Supporting both the associate’s and the company’s working capital requirements.

Disclaimer: The information provided in this blog post is for informational purposes only and should not be construed as investment or trading advice. The author is not a financial advisor and does not have any professional qualifications in this area. The author does not guarantee the accuracy or completeness of the information provided. Any action you take based on the information in this blog post is done at your own risk. Please consult with a financial advisor before making any investment.